A new KFF animation explains how rebates for prescription drugs work, including how they are determined, who benefits from them, how they affect spending by insurers and consumers and the role of pharmacy benefit managers in the process.
The Trump Administration had proposed banning such rebates in Medicare Part D, but dropped the proposal amid concerns that it would lead to higher costs for insurers, consumers and the Medicare program. It is still possible that policymakers could make changes to the rebate system, but they’re also talking about many other ways to lower drug costs.
Visit kff.org to view the animation and see other KFF research and data on prescription drugs.